BR102375 is a non-TZD peroxisome proliferator-activated receptor γ ( PPAR γ ) full agonist for the treatment of type 2 diabetes, reveals EC 50 value of 0.28 μM and A max ratio of 98%.
Products | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Apoptosis | Products > Research Areas > Metabolic Disease | Products > Signaling Pathways > PARP | Products > Signaling Pathways > Apoptosis
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.